HealthNotableSingle-source
5.2
Weight-Loss Drugs Enter Corporate Benefits as Employer Subsidies Rise
Valor Econômico·BR·1 day ago
South Korea's customs agency reported that illegal imports of weight-loss drugs exceeded 5,000 cases by August 2026, indicating a surge in unregulated pharmaceutical inflows. The scale suggests growing demand for unapproved weight-loss treatments, posing public health risks and straining enforcement. The trend may prompt stricter import controls and regulatory action.
Locations
Entities